Mpande Mukumbwa-Mwenechanya

Mpande Mukumbwa-Mwenechanya is a visionary public health executive and supply chain leader with over 15 years of progressive experience driving strategic planning, systems strengthening, and cross-sector collaboration within Zambia's health sector. As Director of Operations at the Zambia Medicines and Medical Supplies Agency (ZAMMSA), she has provided leadership in the warehousing, and nationwide distribution of essential medicines and medical supplies. Previously, as Chief of Party at the Centre for Infectious Disease Research in Zambia (CIDRZ), Mpande successfully led a major PEPFAR-funded initiative to scale up Viral Load and Early Infant Diagnosis testing, strengthening Zambia's HIV care continuum through robust laboratory quality systems, digital health innovations, and effective stakeholder engagement. She managed a $10 million annual budget, aligning project outcomes with both national and donor priorities, and building strong, sustainable partnerships across government, donor, and community stakeholders. Mpande is deeply committed to knowledge sharing, capacity building, and inclusive leadership. She contributes her expertise to national health policy through the Differentiated Service Delivery Task Force and represents Zambia in the CQUIN Monitoring & Evaluation Community of Practice. As a part-time lecturer at the University of Zambia School of Medicine, she mentors future health professionals, further enriching the country's healthcare knowledge base. Her experience spans managing complex scientific studies, leading large multidisciplinary teams, and delivering impactful results in diverse environments across Southern Africa. Her core strengths include strategic leadership, resource mobilization, operational and financial management, systems innovation, and fostering high-performing, inclusive teams. Mpande holds a Bachelor's degree in Pharmacy and a Master's in Clinical Pharmacy from the University of Zambia, a Master of Science in Epidemiology from the London School of Hygiene and Tropical Medicine and is currently pursuing a Doctor of Business Administration specialization in Logistics and Supply Chain Management with the European Institute of Applied Science and Management (Prague). As a young Zambian woman with a proven record of working across government, non-Governmental Organizations (NGOs), and international partners, Mpande is passionate about leading CIDRZ into its next era of strategic growth, operational excellence, and sustainable impact ensuring that empowerment, innovation, and equity remain at the heart of the organization's mission so that no one is left behind

English: First Language

References available upon request.

• Strategic Leadership: Successfully managed multi-million-dollar budgets while ensuring alignment with donor priorities and national strategies.
• Partnership Development: Cultivated long-term collaborations with government ministries, donors (PEPFAR, BMGF), and implementing partners across Southern Africa.
• Capacity Building: Designed impactful training programs for healthcare professionals and community leaders to enhance service delivery outcomes.
• Knowledge Sharing: Represented Zambia in international learning networks such as the CQUIN M&E Community of Practice Committee to share best practices in public health innovation.

The Caeser Mudenda Award for the best fourth year graduating Pharmacy student 2005 - 2006, The Sherlys Pharmaceutical LTD Award for the best final year student in Dosage Form Design and Formulations (DDF) 2006 - 2007, The Sherlys Pharmaceutical LTD Award for the best final year student in Sources and Chemistry of Drugs (SCD) 2006 – 2007

• Registered as a Clinical Pharmacist Specialist with Health Professions Council of Zambia (HPCZ)
• Member Pharmaceutical Society of Zambia (PSZ)
• Fast Track Cities 2019 Faculty Member

• Mpande Mukumbwa-Mwenechanya et al. Immediate and early engagement of same-day antiretroviral therapy initiation among newly diagnosed people living with HIV in urban Zambia: a retrospective cohort study. PAMJ - One Health. 2023;10(1). 10.11604/pamj-oh.2023.10.1.37012 https://www.one-health.panafrican-med-journal.com/content/article/10/1/full
• Mukumbwa-Mwenechanya M, Muhau M, Somwe P, Khozya Zyambo K, Bosomprah S, Sharma A, et al. Integrating Isoniazid Preventive Therapy into the Fast-Track HIV Treatment Model in Urban Zambia: A Proof-of-Concept Pilot Project. PLOS Glob Public Health 2023. https://doi.org/10.1371/journal.pgph.0000909
• Girdwood S, Pandey M, Machila T, Warrier R, Gautam J, Mukumbwa-Mwenechanya M, et al. (2023) The integration of tuberculosis and HIV testing on GeneXpert can substantially improve access and same-day diagnosis and benefit tuberculosis programmes: A diagnostic network optimization analysis in Zambia. PLOS Glob Public Health 3(1): e0001179. https://doi.org/10.1371/journal.pgph.0001179
• Bolton Moore C, Pry JM, Mukumbwa-Mwenechanya M, Eshun-Wilson I, Topp S, Mwamba C, et al. (2022) A controlled study to assess the effects of a Fast Track (FT) service delivery model among stable HIV patients in Lusaka Zambia. PLOS Glob Public Health 2(8): e0000108. https://doi.org/10.1371/journal.pgph.0000108
• Jake Myr P, Kombatice Sikombe, Aaloke Mody, Shilpa Iyer, Jacob Mutale, Mpande Mukumbwa-Mwenechanya, et al; Mitigating the effects of COVID-19 on HIV treatment and care in Lusaka, Zambia: a before–after cohort study using mixed effects regression; BMJ Global Health 2022;7:e007312.
• Jamieson L, Rosen S, Phiri B, Grimsrud A, Mwansa M, Shakowle H, Haimbe P, Mukumbwa-Mwenechanya M, et al. How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from a retrospective cohort study in Zambia. BMJ Open 2022;12:e060470. doi: 10.1136/bmjopen-2021-060470
• Yo Y., Rosen, S., Y. K.T.L., Phiri, B., Huber, A.N., Mwansa, M., Shakowle, H., Haimbe, P., Mukumbwa-Mwenechanya M., Lumano-Mulenga, P. and Nichols, B.E. (2021), Changes in HIV treatment differentiated care uptake during the COVID-19 pandemic in Zambia: interrupted time series analysis. J Int AIDS Soc, 24: e25808. https://doi.org/10.1002/jia2.25808
• Jimmy Mwangeni Hangoma, Steward Mudenda, Mpande Mukumbwa Mwenechanya, Aubrey Chichoni Kalungia; Community pharmacists' knowledge and preparedness to participate in the fight against Coronavirus disease 2019 (COVID-19) in Zambia doi: https://doi.org/10.1101/2020.09.01.20185694
• Monika Roy, Carolyn Bolton-Moore, Lukanj Sikazwe, Mpande Mukumbwa-Mwenechanya, et al; Participation in adherence clubs and on-time drug pickup among HIV-infected adults in Zambia: A matched-pair cluster randomized trial; PLOS Medicine Published: July 1, 2020 https://doi.org/10.1371/journal.pmed.1003116
• Radhika P. Tampi, Taniya Tembo, Mpande Mukumbwa-Mwenechanya, et al; Operational characteristics of antiretroviral therapy clinics in Zambia: a time and motion analysis; BMC Health Services Research, 24th April 2019 https://doi.org/10.1186/s12913-019-4096-z
• Eshun-Wilson, Ingrid, Mukumbwa-Mwenechanya, Mpande, Kim, Hae-Young, Zannolini, Arianna, et al; Differentiated care preferences of stable patients on ART in Zambia A discrete choice experiment; JAIDS, 19th April, 2019 doi:10.1097/QAI.0000000000002070
• L.B. Mulenga, M. Mwenechanya, L. Chirwa, M. Siwingwa, C. Kankasa et al ; Low dose efavirenz (Efavirenz 400mg) combined with tenofovir 300mg and lamivudine 300mg shows excellent viral suppression among HIV pregnant women receiving routine care in Zambia 4-1077-0137-05043;
• Mpande Mukumbwa-Mwenechanya, Muhau Mubiana, Helen Bwalya Mulenga, Chitalu Liyembela, Mwansa Lumpa, Paul Somwe, Mwanza wa Mwanza, Anjali Sharma, Carolyn Bolton-Moore Monitoring Implementation Pace and Quality of Differentiated Services at Scale in Zambia, ICASA2019
• Mpande Mukumbwa-Mwenechanya, Emilie Efronson, Paul Somwe, Jillian L. Kadota, Monika Roy, Samuel Bosomprah, et al: High viremia among ‘stable’ patients receiving Antiretroviral Therapy in Zambia, CROI2018 , www.croiconference.org